Like most websites, we use cookies and other similar technologies for a number of reasons, such as keeping our website reliable and secure, personalizing content, providing social media features and to better understand how our site is used. By using our site, you are agreeing to our use of these tools. Learn More

Your Location is set to:

PROACT-Lung

A Prospective Observational Clinical Validation Study of the Freenome Multiomics Blood Test for Lung Cancer Screening

Objective

A observational study to evaluate the performance of the FMBT-Lung (blood test) in screening eligible participants for lung cancer.

Principal Investigator(s)
Peter Ward, MD

Clinical Trial Categories

  • Observational
  • Lung Cancer
Contact
Meghan Stone, BHS at 508-862-7284
or mestone@capecodhealth.org
How to Participate

Contact your oncologist, oncology nurse or the Oncology Research Program Manager.